2 weeks Ago By Defense World Staff
Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences ( NASDAQ:CALA – Get Free Report ) in a note issued to investors on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance Shares of NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a 52 week low of $0.
00 and a 52 week high of $0.12. The firm has a 50-day moving average price of $0.
02 and a 200 day moving average price of $0.02. About Calithera Biosciences ( Get Free Report ) Further Reading Five stocks we like better than Calithera Biosciences What is Put Option Volume? CarMax’s Impressive Rally: What Investors Should Watch Next Best Stocks Under $5.
00 MarketBeat Week in Review – 9/23 – 9/27 Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance Wake Up to This Biotech Stock That Still Has Big Potential Upside Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter ..
